INTRODUCTION
Despite recent advances in antibiotic therapy and critical care, bacterial meningitis continues to impose high rates of morbidity and mortality. [1] [2] [3] [4] Given that bacterial meningitis freqently has associated poor outcomes, new treatment strategies are needed. Of particular interest is therapeutic hypothermia (TH). It has well documented neuroprotective effects and may have a potential use in selected patients with meningitis. 5, 6 We present case series of adult community-acquired bacterial meningitis treated with hypothermia and describe in detail the methods and the rationale for its use.
PATIENTS AND METHODS
In the period between February 2009 and May 2010, ten patients suffering from severe community-acquired bacterial meningitis were treated with hypothermia. All patients were mechanically ventilated. The following treatment protocol was applied in all patients: mild hypothermia (32-34 o C) accompanied with daily assessment of cerebrovascular carbon dioxide reactivity (CO 2 R) measured by Transcranial Doppler (TCD) and cerebral perfusion using the lactate-oxygen index (LOI) when available. The LOI was not measured in four patients because of difficult internal vein cannulation. Initial antimicrobial treatment consisted of ceftriaxone alone or in combination with ampicillin. Adjuvant steroid treatment was applied in seven patients.
Despite therapeutic hypothermia, two patients died within 48 hours from admission because of refractory intracranial hypertension. Two patients with severe residual neurological deficits (GOS 2) died after discharge from ICU because of late-onset nosocomial sepsis more than a month upon admission. In the surviving six patients, the ICU stay ranged from 8 to 36 (mean 22) days.
Of these survivors, two had severe and two had moderate residual neurological deficit, the most common being spastic hemiparesis and tetraparesis, respectively. One patient remained paraplegic with urinary incontinence due to severe pneumococcal myelitis. Two of the six survivors had a complete neurological recovery. The patients' demographic and clinical data are summarized in Tables 1-3 .
The hospital Ethics Committee approved the treatment protocol and informed consent was obtained from the relatives of all patients.
Transcranial Doppler ultrasound (TCD)
TCD measurement of CO 2 reactivity (CO 2 R) was performed by using a Multidop 4 X (DWL, Sipplingen, Germany) with two 2-MHz pulsed wave probes 1.7 cm in diameter. The software used 
Jugular bulb oximetry
The jugular bulb catheter placement offers an opportunity for the measurement of SjO 2 and calculation of lactate-oxygen index (LOI) using paired arterial and venous blood samples. The measurements were made daily during the period of hypothermia. Desaturation of jugular bulb venous blood (SjO 2 < 55%) with increased cerebral lactate-oxygen index (LOI > 0. 
Hypothermia
We used an internal protocol designed to achieve mild hypothermia (rectal temperature of 32- ml/min, ultrafiltration rate (UFR) to zero ml/h and the replacement solution rate was set to 2000 ml/h.
Enoxaparin was used for anticoagulation of the circuit.
DISCUSSION
While hypothermia has already been used for neuroprotection in a variety of neurological and non-neurological conditions, this method has been exceptionally applied to the treatment of central nervous system infections. 5, 6, [13] [14] [15] [16] Other adjunctive treatment options, such as the use of corticosteroids, despite their beneficial effects in majority of patients have not substantially changed disease outcomes among patients with most severe pneumococcal meningitis. 17 Common neurological sequelae in survivors of bacterial meningitis may result from neuronal damage, ischemic encephalopathy or ischemic stroke. In our opinion, current therapies do not adequately address the underlying pathophysiology leading to neurologic damage associated with bacterial meningitis. Current treatments are frequently aimed at reducing intracranial pressure and depend on cerebral vasoreactivity. 18, 19 In severe bacterial meningitis, however, cerebral blood flow (CBF) autoregulation is often damaged. Furthermore, cerebral metabolic oxygen demand (CMRO 2 ) and CBF coupling is frequently disrupted and leads to multisegmental hypoperfusion or hyperemia.
The use of mannitol in patients with impaired cerebral arterioles carbon dioxide reactivity (CO 2 R) carries the risk for paradoxical aggravation of brain edema because of possible mannitol leakage into the brain tissue . Therefore, the administration of mannitol should be discouraged in such patients. In addition, the appropriate monitoring of cerebral perfusion pressure (CPP), intracranial pressure (ICP), cerebral oxygen demand, consumption and extraction in these patients is necessary.
The effects of mild hypothermia may target the pathophysiological mechanisms that are in effect during bacterial meningitis because most of them are temperature dependent. 20, 21 Hypothermia results in neuroprotection through a variety of mechanisms. Decreased body temperature causes reduced production of reactive oxygen and nitrogen species, inhibition of the neuroexcitatory cascade, a reduction in proinflammatory cytokine level, maintenance of blood-brain barrier integrity, decreased intracranial pressure, and finally decreased neuronal apoptosis. [22] [23] [24] [25] [26] [27] [28] Additionally, adverse events are noted to be rare. When those events occur, they are typically minor. 5 According to our framework, the selection of patients for induced hypothermia is primarily based on cerebral arterioles CO 2 reactivity. The criteria for therapeutic hypothermia are GCS ≤ 8 accompanied with optic nerve sheath diameter (ONSD) > 6.0 mm if the temporal acoustic window is absent and cerebral vasoreactivity cannot be assessed.
Because of strong correlation of BHI with the severity (particularly with GCS score) and the outcome of the disease, we defined the BHI level of ≤ 0.86 as inclusion criteria for hypothermia.
Chemoregulation in our patients was severely impaired or completely absent.
We believe that marked reduction of CO 2 reactivity, measured by TCD, accompanied with increased ONSD and altered mental status (GCS ≤ 8 ) reliably select patients who are candidates for urgent hypothermia induction. In patients with preserved CO 2 reactivity, the use of hypothermia probably would not yield additional benefit when compared to the standard treatment regimen. The mortality rate in patients with bacterial meningitis and preserved vasoreactivity treated with standard regimen regardless of disease severity was zero (0/14) compared with 25% (5/20) in patients with impaired vasoreactivity (unpublished data).
In all patients with jugular bulb catheter the measurements showed cerebral perfusion impairment (increased LOI) ( Table 3) . Vasopressors were used to support cerebral perfusion pressure (CPP). Low doses of norepinephrine infusion in addition to hypothermia were sufficient to significantly improve the MBFV and LOI without significant systemic hypertension. A marked reduction in ONSD during hypothermia was also noted (Table 3) .
With respect to disease severity, the outcome of our patients was generally satisfactory (Table 1) . If the standard treatment regimen had been applied the disease would likely have been fatal. At admission, one patient had TCD signs of cerebral circulatory arrest while the others were elderly and had severe global cerebral hypoperfusion. The mortality rate in such patients reaches 69%. 3 While lowering of body temperature may take several hours in pyretic patients, CVVHF allows the maintenance of a stable body temperature. Our patients had no significant variations in body temperature. In addition, the use of CVVHF allows gradual rewarming of the patient upon recovery.
While there is evidence from animal studies that hypothermia may be beneficial in meningitis and while scarce clinical experience suggests a role for hypothermia, large scale randomized clinical trials are needed. 27, 28 Inclusion criteria in these trials should be based primarily on the cerebral Despite numerous favorable effects of hypothermia, a more comprehensive approach should be employed. It may be taken into account as an adjunctive therapy that has a role alongside established treatments. According to our findings, hypothermia in carefully selected patients holds promise. Legend:
1 BHIm = mean breath holding index (normal range: 1,03 -1,65)
2 ONSD = optic nerve sheath diameter (normal value < 5,0 mm) 3 LOI = lactate-oxygen index (normal value < 0,03)
